The Valley Desk

NCT01313637 · Interventional trial

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

Overall registry status Completed

Phase 3

Conditions Pulmonary Disease, Chronic Obstructive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov